Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Carrington Reports Third Quarter 2004 Results
Company reports revenues of $7.73 million for the quarter with a profit of $980,000 before funding of DelSite Biotechnologies, Inc., the company's research and development subsidiary, revenue of $7.53 million with a net to a loss of $466,000 reported previous year.
- NLI Expands Production Capacity to Meet Client Demand
Company brings on-line a second manufacturing facility in the Missoula, Montana area to increase manufacturing capacity by over 80%.
- NLI Expands Production Capacity to Meet Client Demand
Company brings on-line a second manufacturing facility in the Missoula, Montana area to increase manufacturing capacity by over 80%.
- NLI Expands Production Capacity to Meet Client Demand
Company brings on-line a second manufacturing facility in the Missoula, Montana area to increase manufacturing capacity by over 80%.
- NLI Expands Production Capacity to Meet Client Demand
Company brings on-line a second manufacturing facility in the Missoula, Montana area to increase manufacturing capacity by over 80%.
- Imperial Ginseng Products Ltd. Reports First Quarter 2005 Fiscal Year Results
Company reports revenues of $1,197,259 and net loss of $121,341 for the quarter, compares to revenues of $154,578 and net income of $141,825 prior year.
- Imperial Ginseng Products Ltd. Reports First Quarter 2005 Fiscal Year Results
Company reports revenues of $1,197,259 and net loss of $121,341 for the quarter, compares to revenues of $154,578 and net income of $141,825 prior year.
- Forbes Medi-Tech Announces Financial Results for the Third Quarter
Company reports revenues of $5.4 million for the quarter, compared to $3.4 million prior year.
- Forbes Medi-Tech Announces Financial Results for the Third Quarter
Company reports revenues of $5.4 million for the quarter, compared to $3.4 million prior year.
- MFIC's Microfluidizer Processor Plays Pivotal Role in UMass Lowell's Nutraceutical Research
University of Massachusetts Lowell scientists are using Microfluidizer(R) materials processing equipment to develop water soluble plant sterols for use as cholesterol-blocking food additives.
- MFIC's Microfluidizer Processor Plays Pivotal Role in UMass Lowell's Nutraceutical Research
University of Massachusetts Lowell scientists are using Microfluidizer(R) materials processing equipment to develop water soluble plant sterols for use as cholesterol-blocking food additives.
- Burcon Announces Second Quarter Results
Company rports net loss of $912,598 for the quarter, compared to loss of $622,374 prior year, with cash position at end of period at $2,294,560, with working capital of $2,070,345.
- Burcon Announces Second Quarter Results
Company rports net loss of $912,598 for the quarter, compared to loss of $622,374 prior year, with cash position at end of period at $2,294,560, with working capital of $2,070,345.
- Bio-One Q3 Reports Revenue of $10.4M, Operating Income of $938,000
Company reports increase of 517% in net sales, net loss of ($1,265,003)after deducting non-operating expenses of depreciation, amortization and interest.
- Bio-One Q3 Reports Revenue of $10.4M, Operating Income of $938,000
Company reports increase of 517% in net sales, net loss of ($1,265,003)after deducting non-operating expenses of depreciation, amortization and interest.
- Health & Nutrition Systems Reports Third Quarter Results
Company reports profit of $185,899 for the quarter, compared with roughly same ammount previous year; revenues were $2,370,380, compared to $1,867,887 for the same period in 2003.
- Health & Nutrition Systems Reports Third Quarter Results
Company reports profit of $185,899 for the quarter, compared with roughly same ammount previous year; revenues were $2,370,380, compared to $1,867,887 for the same period in 2003.
- Lifeway Foods Reports Third Quarter and Nine Month Results
Company reports quarterly sales of $4.14 million compared to $3.83 million prior year, with net income of $515,109, compared to $709,196 pervious year.
- Lifeway Foods Reports Third Quarter and Nine Month Results
Company reports quarterly sales of $4.14 million compared to $3.83 million prior year, with net income of $515,109, compared to $709,196 pervious year.
- Announcement of the 2003/04 financial results of the Chr. Hansen Group and Chr. Hansen Holding A/S
Company announces revenue of food ingredients group increases 8%; target for 04/05 is 5-6% organic growth.
- Announcement of the 2003/04 financial results of the Chr. Hansen Group and Chr. Hansen Holding A/S
Company announces revenue of food ingredients group increases 8%; target for 04/05 is 5-6% organic growth.
- Forbes Medi-Tech Appoints Dr. Steven Nissen to Chairman of Medical & Scientific Advisory Board
Dr. Nissen is a respected cardiologist who has authored more than 200 journal articles, book chapters, and CD-ROMs, mostly in the field of cardiovascular imaging.
- Forbes Medi-Tech Appoints Dr. Steven Nissen to Chairman of Medical & Scientific Advisory Board
Dr. Nissen is a respected cardiologist who has authored more than 200 journal articles, book chapters, and CD-ROMs, mostly in the field of cardiovascular imaging.
- Forbes Medi-Tech Appoints Dr. Steven Nissen to Chairman of Medical & Scientific Advisory Board
Dr. Nissen is a respected cardiologist who has authored more than 200 journal articles, book chapters, and CD-ROMs, mostly in the field of cardiovascular imaging.
- Forbes Medi-Tech Appoints Dr. Steven Nissen to Chairman of Medical & Scientific Advisory Board
Dr. Nissen is a respected cardiologist who has authored more than 200 journal articles, book chapters, and CD-ROMs, mostly in the field of cardiovascular imaging.
- Unigen Pharmaceuticals Partners with Canadian Company on Novel Weight Reduction Product
Companies to collaborate in producing and commercializing a natural weight reduction product using Unigen’s patent-pending, proprietary compound which aids in achieving weight reduction.
- Unigen Pharmaceuticals Partners with Canadian Company on Novel Weight Reduction Product
Companies to collaborate in producing and commercializing a natural weight reduction product using Unigen’s patent-pending, proprietary compound which aids in achieving weight reduction.
- Unigen Pharmaceuticals Partners with Canadian Company on Novel Weight Reduction Product
Companies to collaborate in producing and commercializing a natural weight reduction product using Unigen’s patent-pending, proprietary compound which aids in achieving weight reduction.
- Unigen Pharmaceuticals Partners with Canadian Company on Novel Weight Reduction Product
Companies to collaborate in producing and commercializing a natural weight reduction product using Unigen’s patent-pending, proprietary compound which aids in achieving weight reduction.
- Unigen Pharmaceuticals Partners with Canadian Company on Novel Weight Reduction Product
Companies to collaborate in producing and commercializing a natural weight reduction product using Unigen’s patent-pending, proprietary compound which aids in achieving weight reduction.
- Unigen Pharmaceuticals Partners with Canadian Company on Novel Weight Reduction Product
Companies to collaborate in producing and commercializing a natural weight reduction product using Unigen’s patent-pending, proprietary compound which aids in achieving weight reduction.
- Unigen Pharmaceuticals Partners with Canadian Company on Novel Weight Reduction Product
Companies to collaborate in producing and commercializing a natural weight reduction product using Unigen’s patent-pending, proprietary compound which aids in achieving weight reduction.
- Unigen Pharmaceuticals Partners with Canadian Company on Novel Weight Reduction Product
Companies to collaborate in producing and commercializing a natural weight reduction product using Unigen’s patent-pending, proprietary compound which aids in achieving weight reduction.
- Unigen Pharmaceuticals Partners with Canadian Company on Novel Weight Reduction Product
Companies to collaborate in producing and commercializing a natural weight reduction product using Unigen’s patent-pending, proprietary compound which aids in achieving weight reduction.
- Unigen Pharmaceuticals Partners with Canadian Company on Novel Weight Reduction Product
Companies to collaborate in producing and commercializing a natural weight reduction product using Unigen’s patent-pending, proprietary compound which aids in achieving weight reduction.
- Vital Living Reports Financial Performance for Third Quarter 2004
Company reports revenues increase from $40,600 to $1,061,025 for the quarter, while net losses before discontinued operations decreased 76.2% to $2,719,949 from $11,437,637.
- Vital Living Reports Financial Performance for Third Quarter 2004
Company reports revenues increase from $40,600 to $1,061,025 for the quarter, while net losses before discontinued operations decreased 76.2% to $2,719,949 from $11,437,637.
- Forbes Medi-Tech Signs International Reducol (tm) Sales and Licensing Agreement
Company Signs Agreement for dairy based products with Fayrefield Foods, United Kingdom.
- Forbes Medi-Tech Signs International Reducol (tm) Sales and Licensing Agreement
Company Signs Agreement for dairy based products with Fayrefield Foods, United Kingdom.
- Health & Nutrition Systems Files Plan of Reorganization
Company has filed its plan of reorganization under Chapter 11 of the federal bankruptcy law.
- Health & Nutrition Systems Files Plan of Reorganization
Company has filed its plan of reorganization under Chapter 11 of the federal bankruptcy law.
- Corn Products International, Inc. Announces Manufacturing Optimization Plans; Two Plants Scheduled for Closure
Company plans to close one of its starch plants in Guadalajara, Mexico (Cisne), and one of its facilities in the Company's Andean region in South America, with closing to be effective for fourth quarter.
- Corn Products International, Inc. Announces Manufacturing Optimization Plans; Two Plants Scheduled for Closure
Company plans to close one of its starch plants in Guadalajara, Mexico (Cisne), and one of its facilities in the Company's Andean region in South America, with closing to be effective for fourth quarter.
- Health Sciences Group Acquires Exclusive Worldwide License from Cornell University for Ultra-Potent Antioxidant Technology
Company announces that it acquired the exclusive worldwide license to a powerful antioxidant derived from the apple peel.
- Health Sciences Group Acquires Exclusive Worldwide License from Cornell University for Ultra-Potent Antioxidant Technology
Company announces that it acquired the exclusive worldwide license to a powerful antioxidant derived from the apple peel.
- Health Sciences Group Acquires Exclusive Worldwide License from Cornell University for Ultra-Potent Antioxidant Technology
Company announces that it acquired the exclusive worldwide license to a powerful antioxidant derived from the apple peel.
- Health Sciences Group Acquires Exclusive Worldwide License from Cornell University for Ultra-Potent Antioxidant Technology
Company announces that it acquired the exclusive worldwide license to a powerful antioxidant derived from the apple peel.
- Brandywine Business Services, Ltd. to Merge With Compound Healthcare and Target Nutraceutical Market
Companies to focus on acquisition opportunities in the healthcare field with emphasis on the worldwide demand for nutraceuticals that have undergone clinical trials for safety and effectiveness.
- Brandywine Business Services, Ltd. to Merge With Compound Healthcare and Target Nutraceutical Market
Companies to focus on acquisition opportunities in the healthcare field with emphasis on the worldwide demand for nutraceuticals that have undergone clinical trials for safety and effectiveness.
- Forbes Medi-Tech Expands Reducol(tm) Business into Scandinavia with Scanvit Ltd, Finland
Company announces that it has agreed to supply Reducol(tm) for use in milk-based drinks to Scanvit Ltd., a Finnish healthcare company.
- Forbes Medi-Tech Expands Reducol(tm) Business into Scandinavia with Scanvit Ltd, Finland
Company announces that it has agreed to supply Reducol(tm) for use in milk-based drinks to Scanvit Ltd., a Finnish healthcare company.
- Mosaic Nutraceutical Signs Exclusive International Distribution Agreement with AHB Trading Limited for Mexico, Central and South America
Mosaic expects to start shipping orders of Celaprix and Lipotrene to AHB within the next 45 days.
- Mosaic Nutraceutical Signs Exclusive International Distribution Agreement with AHB Trading Limited for Mexico, Central and South America
Mosaic expects to start shipping orders of Celaprix and Lipotrene to AHB within the next 45 days.
- Honson Ingredients Celebrates Ten Year Anniversary
Company launches new website and looks forward to 2005.
- Honson Ingredients Celebrates Ten Year Anniversary
Company launches new website and looks forward to 2005.
- Pharming Raises Funds to Accelerate Development of Product Portfolio
Company has placed 3 million new shares with professional long term investors to accelerate development of its product portfolio; proceeds to be used for portfolio products, including recombinant human lactoferrin and fibrinogen.
- Pharming Raises Funds to Accelerate Development of Product Portfolio
Company has placed 3 million new shares with professional long term investors to accelerate development of its product portfolio; proceeds to be used for portfolio products, including recombinant human lactoferrin and fibrinogen.
- Health Sciences Group Acquires Apple Peel Technologies, Inc. from UTEK Corporation
Health Sciences Group has acquired Apple Peel Technologies, Inc. ("APTI"), a wholly-owned subsidiary of UTEK Corporation, in a stock transaction.
- Health Sciences Group Acquires Apple Peel Technologies, Inc. from UTEK Corporation
Health Sciences Group has acquired Apple Peel Technologies, Inc. ("APTI"), a wholly-owned subsidiary of UTEK Corporation, in a stock transaction.
- Tate & Lyle buys leading South African ingredients company Dolcré Food Ingredients (Pty) Ltd.
Dolcré's ingredient portfolio also includes modified starches, sweeteners, pectins, maltodextrins, fat replacers, flavours and nutraceuticals.
- Tate & Lyle buys leading South African ingredients company Dolcré Food Ingredients (Pty) Ltd.
Dolcré's ingredient portfolio also includes modified starches, sweeteners, pectins, maltodextrins, fat replacers, flavours and nutraceuticals.
- United Natural Foods Announces 25% Increase in Net Sales for First Quarter 2005
Company reports sales of $478 million compared to $381.4 million with income increasing 50.0% to $9.9 million for the quarter.
- United Natural Foods Announces 25% Increase in Net Sales for First Quarter 2005
Company reports sales of $478 million compared to $381.4 million with income increasing 50.0% to $9.9 million for the quarter.
- Forbes Medi-Tech's Manufacturing Facility Expanded to 1500 Metric Tonnes
Phyto-Source, LP plant's capacity has been increased by 50% from 1000 metric tonnes annually to 1,500 metric tonnes in anticipation of increased demand.
- Forbes Medi-Tech's Manufacturing Facility Expanded to 1500 Metric Tonnes
Phyto-Source, LP plant's capacity has been increased by 50% from 1000 metric tonnes annually to 1,500 metric tonnes in anticipation of increased demand.
- Soft Gel Technologies, Inc.® Awarded U.S. Patent for Soft Gelatin Formulation of Injuv® Low Molecular Weight Hyaluronic Acid
Company awarded U.S. Patent #6,806,259 for their Injuv® soft gelatin capsule formulation preparation.
- Soft Gel Technologies, Inc.® Awarded U.S. Patent for Soft Gelatin Formulation of Injuv® Low Molecular Weight Hyaluronic Acid
Company awarded U.S. Patent #6,806,259 for their Injuv® soft gelatin capsule formulation preparation.
- Soft Gel Technologies, Inc.® Awarded U.S. Patent for Soft Gelatin Formulation of Injuv® Low Molecular Weight Hyaluronic Acid
Company awarded U.S. Patent #6,806,259 for their Injuv® soft gelatin capsule formulation preparation.
- Soft Gel Technologies, Inc.® Awarded U.S. Patent for Soft Gelatin Formulation of Injuv® Low Molecular Weight Hyaluronic Acid
Company awarded U.S. Patent #6,806,259 for their Injuv® soft gelatin capsule formulation preparation.
- Soft Gel Technologies, Inc.® Awarded U.S. Patent for Soft Gelatin Formulation of Injuv® Low Molecular Weight Hyaluronic Acid
Company awarded U.S. Patent #6,806,259 for their Injuv® soft gelatin capsule formulation preparation.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
|
A Fonterra Co-operative milk protein chemist, with a distinguished career in dairy science spanning more than forty years, has been awarded the world’s top dairy honour for his contribution to the industry.
Dr Lawrie Creamer is the first New Zealander to be awarded the International Dairy Federation (IDF) Award, which he shares with Professor Pierpaolo Resmini from the Department of Food Science and Technology at the State University of Milan (Italy).
The awards were announced today by the IDF at its annual conference in Melbourne in association with the Global Dairy Summit.
Dr Creamer, Principal Research Scientist at Fonterra’s marketing and innovation division in Palmerston North, joined the then Dairy Research Institute (N.Z.), as a protein chemist in 1963 after graduating with a PhD from the University of Canterbury.
At the time, says Dr Creamer, the New Zealand dairy industry was facing a major challenge – the prospect of the United Kingdom joining the European Economic Community and the loss of its previously secure market for dairy products.
This prompted a substantial change of direction for the Dairy Research Institute, with the addition of a team of internationally trained scientists and technologists to build the science and technology needed to diversify into new markets with products that suited those markets.
“The only significant exports in 1960 were a salted butter and a Cheddar cheese to feed post-War Britain,” says Dr Creamer.
“It was a bit of a gamble to invest in a nucleus of young research scientists but the dairy industry’s survival depended on the development of new and often unique products and techniques and it paid off.”
After undertaking postgraduate work from 1964 -1966 at the prestigious Massachusetts Institute of Technology in the United States, Dr Creamer returned to the New Zealand Dairy Research Institute (NZDRI) to lead a research programme on the chemistry of milk proteins and their interactions. This was to place him at the cutting edge of dairy research worldwide.
Dr Creamer’s early work led to many improvements in the manufacture of traditional dairy products such as cheese and milk powders. A major focus was to influence the industry to manufacture consistently high quality Cheddar cheese and to develop a range of non-Cheddar cheeses. His innovative studies on the relationship of texture and flavour in cheese helped define its compositional characteristics.
Dr Creamer attracted a group of scientists and the team tackled a number of the basic questions in dairy chemistry such as, “What happens when milk is heated?” and “How does that impact on a product?”
The team’s fundamental work on milk protein structures, which has not been surpassed, led to the award of the Miles-Marschall Award in 1984, and established the New Zealand–led team as the pre-eminent research group in this area.
Likewise, he and his team have led the way in research into the heat-induced changes to milk and the aggregation of the proteins in whey. Whey proteins, an important byproduct of cheese or casein manufacture, once regarded as a suitable only for animal feed, are now used in a range of food products.
Another line of research was into the hydrolysis of proteins, as one of the processes used to make and to mature cheese, leading to an understanding of the relationship between cheese composition, texture and flavour.
A separate area of work, which examined how dairy farmers should be paid for their milk, resulted in a system of payment based on kilograms of milk fat and protein solids.
Since 1990, when he was appointed Principal Research Scientist at the NZDRI, Dr Creamer has focused more intensively on the structure of the major whey protein, beta-lactoglobulin, and the effect on it of heat and its ability to bind vitamins.
Dr Creamer says his later work reflects the separation of protein science into the more practical studies on cheese, milk protein products and milk powder, and the examination of the more fundamental basis of the interactions between the milk proteins that will drive development of value-add products with the characteristics major dairy customers want.
Recent research, in collaboration with scientists from Massey University’s Riddet Centre and Professors Lindsay Sawyer and Paul Barlow at Edinburgh University, showed that at high temperature the structure of beta-lactoglobulin changes, forming a new protein, which reacts with other smaller milk proteins. This reaction is the basis for the heat stability of milk powders and slower coagulation of heated milks.
Another project is NMR (nuclear magnetic resonance spectroscopy) studies of water molecules to increase understanding of the effects of flow on the redistribution of components in cheese-like substances in collaboration with Professor Paul Callaghan at Victoria University’s McDiarmid Institute. All three projects are partly funded by the Foundation for Research, Science and Technology.
In addition to his own research, Dr Creamer has supervised many Masters and PhD students, providing scientific training for those who will carry on dairy-oriented research in the future. He is widely published and cited author in scientific journals and an editor on some of the leading international dairy journals.
As well as his latest IDF honour, Dr Creamer, a Fellow of the New Zealand Institute of Chemistry, is the recipient of some 14 awards in recognition of his immense contribution to dairy science. In 1961, he received the New Zealand Dairy Research Institute Fellowship, which enabled him to travel to the Massachusetts Institute of Technology for advanced study, setting the path for his 40-year career.
In 1973, he was awarded the ICI New Zealand Ltd Prize “for outstanding achievement in chemical research” and in 1984 the Miles-Marschall International ADSA Award by the American Dairy Science Association. Dr Creamer was the youngest recipient of the Award at that time, which recognises those working outside North America for research that leads to better dairy products.
In 1995, he was elected a Fellow of the Royal Society of New Zealand, the highest New Zealand science accolade and in 1999 the Society presented him with the RJ Scott Medal in Engineering Sciences and Technologies. He is married with three sons and a daughter and, in keeping with his strong community service ethic is a Justice of the Peace.
ENDS
|